Biotech · Private company · Morrisville, NC, US
Health Decisions, Inc.
Track this companyFree. Adds Health Decisions, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTIONFiscal year 2025 · $700.2KNIH RePORTER 75N94019D00004-0-759402500001-1 · fetched Nov 12, 2026
- NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLEFiscal year 2025 · $233.3KNIH RePORTER 75N94019D00004-0-759402500002-1 · fetched Nov 12, 2026
- PROTOCOL FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIALFiscal year 2025 · $60.8KNIH RePORTER 75N94019D00004-P00004-759402300003-1 · fetched Nov 12, 2026
- COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTIONFiscal year 2025 · $701.6KNIH RePORTER 75N94019D00004-P00007-759402300001-1 · fetched Nov 12, 2026
- A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTIONFiscal year 2025 · $875.6KNIH RePORTER 75N94019D00004-P00007-759402300002-1 · fetched Nov 12, 2026
- CORE FUNCTION ACTIVITIES - NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTERFiscal year 2025 · $535.2KNIH RePORTER 75N94019D00004-P00019-759401900125-1 · fetched Nov 12, 2026
- CCTN - EVALUATION OF THE PHARMACOKINETIC PROFILE AND EFFECTS ON MECHANISMS OF CONTRACEPTIONFiscal year 2024 · $47.1KNIH RePORTER 275201200002I-P00011-27500005-1 · fetched Nov 12, 2026
- PROTOCOL FINALIZATION, START-UP, COORDINATION, MONITORING, AND ALL OTHER ASSOCIATED ACTIVITIES FOR CLINICAL TRIALS EVALUATING PROGESTOGENIC ANDROGENS AS CONTRACEPTIVE AGENTSFiscal year 2024 · $994.1KNIH RePORTER 75N94019D00004-0-759402400001-1 · fetched Nov 12, 2026
- ACQUISITION OF THE NESTORONE ESTRADIOL (NES/E2) VAGINAL RING AS CONTRACEPTIVEFiscal year 2024 · $1.2MNIH RePORTER 75N94019D00004-0-759402400002-1 · fetched Nov 12, 2026
- A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTIONFiscal year 2024 · $810.5KNIH RePORTER 75N94019D00004-P00001-759402300002-1 · fetched Nov 12, 2026